Peginterferon alfa-2b Subcutaneous and Zemplar (Paricalcitol Capsules)
Determining the interaction of Peginterferon alfa-2b Subcutaneous and Zemplar (Paricalcitol Capsules) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: peginterferon alfa-2b
Brand name: PegIntron, Sylatron, PegIntron Redipen
Synonyms: Peginterferon alfa-2b, Peginterferon Alfa-2b
Generic Name: paricalcitol
Brand name: Zemplar
Synonyms: Zemplar
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Peginterferon alfa-2b Subcutaneous-Zemplar (Paricalcitol Injection)
- Peginterferon alfa-2b Subcutaneous-Zemplar Injection
- Peginterferon alfa-2b Subcutaneous-Zemplar Intravenous
- Peginterferon alfa-2b Subcutaneous-Zemuron
- Peginterferon alfa-2b Subcutaneous-Zenapax
- Peginterferon alfa-2b Subcutaneous-Zenatane
- Zemplar (Paricalcitol Capsules)-Peginterferon beta-1a
- Zemplar (Paricalcitol Capsules)-Peginterferon beta-1a Subcutaneous
- Zemplar (Paricalcitol Capsules)-PegIntron
- Zemplar (Paricalcitol Capsules)-Pegloticase
- Zemplar (Paricalcitol Capsules)-Pegloticase Intravenous
- Zemplar (Paricalcitol Capsules)-Pegvaliase